The need for a global HIV vaccine enterprise Journal Article


Authors: Klausner, R. D.; Fauci, A. S.; Corey, L.; Nabel, G. J.; Gayle, H.; Berkley, S.; Haynes, B. F.; Baltimore, D.; Collins, C.; Gordon Douglas, R.; Esparza, J.; Francis, D. P.; Ganguly, N. K.; Gerberding, J. L.; Johnston, M. I.; Kazatchkine, M. D.; McMichael, A. J.; Makgoba, M. W.; Pantaleo, G.; Piot, P.; Shao, Y.; Tramont, E.; Varmus, H.; Wasserheit, J. N.
Article Title: The need for a global HIV vaccine enterprise
Keywords: clinical trial; review; nonhuman; human immunodeficiency virus infection; organization and management; drug screening; drug evaluation, preclinical; drug design; biotechnology; standard; financial management; economics; immunology; multicenter study; immunogenicity; vaccination; clinical research; organization; human immunodeficiency virus; acquired immune deficiency syndrome; virus infection; health; clinical laboratory; public policy; clinical trials; hiv infections; policy; human immunodeficiency virus 1; international cooperation; patent; hiv-1; world health; drug industry; drug manufacture; intellectual property; multicenter studies; human immunodeficiency virus vaccine; private sector; aids vaccines; academies and institutes; good manufacturing practice; research support; public sector; humans; human; priority journal; article; financial support
Journal Title: Science
Volume: 300
Issue: 5628
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2003-06-27
Start Page: 2036
End Page: 2039
Language: English
DOI: 10.1126/science.1086916
PUBMED: 12829768
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 25 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Harold Varmus
    96 Varmus